128 related articles for article (PubMed ID: 17997890)
21. Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.
Sangiolo D; Martinuzzi E; Todorovic M; Vitaggio K; Vallario A; Jordaney N; Carnevale-Schianca F; Capaldi A; Geuna M; Casorzo L; Nash RA; Aglietta M; Cignetti A
Int Immunol; 2008 Jul; 20(7):841-8. PubMed ID: 18469328
[TBL] [Abstract][Full Text] [Related]
22. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
23. [The treatment with allogeneic peripheral blood stem cell transplantation for benzene-induced severe aplastic anemia].
Huang ZQ; Chen JY; Cao LX; Wu JM; Jiang CQ; Liu WW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Aug; 21(4):241-3. PubMed ID: 14761424
[TBL] [Abstract][Full Text] [Related]
24. [The functional mechanism of CIK cells on ovarian carcinoma cell lines SKOV3/CDDP].
Zhang H; Zhao Q; Zuo LF; Ma HJ; Li SR; Cheng JX; Jia JH; Kang S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1167-9. PubMed ID: 18062892
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial.
Olioso P; Giancola R; Di Riti M; Contento A; Accorsi P; Iacone A
Hematol Oncol; 2009 Sep; 27(3):130-9. PubMed ID: 19294626
[TBL] [Abstract][Full Text] [Related]
26. [Proliferation and cytotoxicity of RetroNectin-activated cytokine-induced killer cells against cisplatin-resistant lung carcinoma cell].
Ren W; Wang Z
Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1373-80. PubMed ID: 18998538
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic effect of autologous cytokine-induced killer cells on patients with liver cirrhosis caused by HBV infection].
Su HB; Li HW; Zhao HL; Shi M; Zhang B; Tang ZR; Lei ZY; Wang HF; Wang FS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):64-6. PubMed ID: 17429540
[TBL] [Abstract][Full Text] [Related]
28. [Short-term curative efficacy of cytokine-induced killer cells combined micro-invasive treatments on hepatocellular carcinoma].
Zhou QM; Wu PH; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 Nov; 25(11):1414-8. PubMed ID: 17094912
[TBL] [Abstract][Full Text] [Related]
29. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer cells.
Li Y; Schmidt-Wolf IG; Wu YF; Huang SL; Wei J; Fang J; Huang K; Zhou DH
Anticancer Res; 2010 Sep; 30(9):3493-9. PubMed ID: 20944128
[TBL] [Abstract][Full Text] [Related]
30. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
[TBL] [Abstract][Full Text] [Related]
31. [Clinical efficacy of immunotherapy of dendritic cell and cytokine-induced killer cell combined with chemotherapy for treatment of multiple myeloma].
Zhong GC; Yan B; Sun Y; Zhang XY; Chen J; Su Y; Sun HP; Zhu B
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1000-3. PubMed ID: 23363790
[TBL] [Abstract][Full Text] [Related]
32. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
[TBL] [Abstract][Full Text] [Related]
33. Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection.
Shi M; Fu J; Shi F; Zhang B; Tang Z; Jin L; Fan Z; Zhang Z; Chen L; Wang H; Lau GK; Wang FS
Clin Immunol; 2009 Jul; 132(1):43-54. PubMed ID: 19328038
[TBL] [Abstract][Full Text] [Related]
34. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.
Leemhuis T; Wells S; Scheffold C; Edinger M; Negrin RS
Biol Blood Marrow Transplant; 2005 Mar; 11(3):181-7. PubMed ID: 15744236
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of an automated closed fluid management device for processing expanded cytokine-induced killer cells to use in immunotherapy programs for cancer.
Giancola R; Olioso P; Di Riti M; Capone A; Contento A; Pompetti F; Iacone A
Transfusion; 2008 Apr; 48(4):629-39. PubMed ID: 18208417
[TBL] [Abstract][Full Text] [Related]
36. Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion.
Shi M; Fu J; Shi F; Zhang B; Tang Z; Zhang Z; Zhang H; Jin L; Chen L; Wang H; Akbar SM; Wang FS
Liver Int; 2009 Mar; 29(3):466-74. PubMed ID: 18710425
[TBL] [Abstract][Full Text] [Related]
37. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
38. [The cytotoxicity of CIK/NK cells stimulated by K562-DC fusion vaccines in NOD/SCID mice model for human erythroleukemia].
Li Y; Huang SL; Zhang XC; Fang JP; Wu YF; Wei J; Huang WG; Zhou DH; Huang K; Lin YC
Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):39-43. PubMed ID: 18512314
[TBL] [Abstract][Full Text] [Related]
39. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.
Weng DS; Zhou J; Zhou QM; Zhao M; Wang QJ; Huang LX; Li YQ; Chen SP; Wu PH; Xia JC
J Immunother; 2008 Jan; 31(1):63-71. PubMed ID: 18157013
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]